Alto Pharmacy, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Alto Pharmacy, LLC - overview

Established

2015

Location

San Francisco, CA, US

Primary Industry

Healthcare IT

About

Alto Pharmacy, LLC is a U. S. -based healthcare company specializing in pharmacy services that enhance patient experiences through technology-driven solutions and specialized medication delivery. Founded in 2015 and headquartered in San Francisco, US, Alto Pharmacy, LLC focuses on providing innovative pharmacy services.


The company has undergone strategic pivots to emphasize technology in medication management. Jamie Karraker, Lisa Dashiell, and Mattieu Gamache-Asselin are the founders, while Alicia Davis serves as the CEO. Alto has successfully raised USD 120. 00 mn through 12 funding rounds, with the latest round occurring recently, achieving a current valuation of USD 800.


00 mn. Alto Pharmacy offers a range of pharmacy services designed to improve patient care through technological integration. Their platform features an app for managing prescription orders and payments, providing both same-day delivery and pharmacy pick-up services. Notably, Alto specializes in fertility medications, supporting over 160,000 fertility journeys since 2016, with services available nationwide across all 50 states.


The company generates revenue through a transaction model encompassing direct-to-consumer and business-to-business interactions, largely through partnerships with healthcare providers and fertility clinics. Revenue primarily comes from prescription fulfillment services, including the delivery of specialty medications. The Alto app facilitates convenience in ordering medications and may include subscription options for ongoing needs, enhancing their service value. Alto Pharmacy plans to leverage recent funding from GDP Venture to further develop its technology and expand its market presence.


The company is focused on launching new product offerings aimed at enhancing customer engagement and improving healthcare access. Specific geographic expansions are targeted, although precise regions and timelines are not disclosed. The funding will support these growth initiatives, enabling Alto to enhance its service capabilities and reach more patients.


Current Investors

Greenoaks Capital, Jackson Square Ventures, Soma Capital Management

Primary Industry

Healthcare IT

Sub Industries

Courier & Delivery Services, Healthcare IT, Social Networking & Communication Platform

Website

www.alto.com

Verticals

HealthTech, Mobile Apps

Company Stage

Series E

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.